1Scagliotti GV.Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer[J].Semin Oncol,2005,32(2Sup-P12):55-58.
2Adjei AA.Pharmacology and mechanismof action of pemetrexed[J].Clin Lung Cancer,2004,5(Suppl 2):51-55.
3Thodtmann R,Depenbrock H,Dumez H,et al.Clinical and pharmacokinetic phase study of multitargeted antifolate (LY231514)in combination with cisplatin[J].J Clin Oncol,1999,17(10):3009-3016.
4Chattopadhyay S,Zhao R,Krupenko SA,et al.The inverse relationship between reduced folatc cartier function and pemetrexed activity in a human colon cancer cell line[J].Mol Cancer Ther,2006,5(2):438-449.
5Janne PA,Simon GR,Langer CJ.Phase II trial of pemetrexedand gemcitabine in chemotherapy-naive malignant pleural mesothelioma[J].J Clin Oncol,2008,26(9):1465-1471.
6Taylor P,Castagneto B,Dark G,et al.Single-agent pemetrexed for chemonaive and pretreated pailents witll nitllignant pleural mesotllelioma:results of an International Expan ded Access Program[J].J Thorac Oncol,2008,3(7):764-771.
10Hanna N,Shepherd FA,Fossella FV,et al.Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy[J].J Clin Oncol,2004,22(9):1589-1597.
2Muers MF,Stephens RJ,Fisher P,et al. Active symptomcontrol with or without chemotherapy in the malignant pleural mesothelioma:a multicentre randomized trial [J]. Lancet, 2008,371 (9625) : 1685-1694.
3Van Meerbeeck JP,Gaafar R, Manegold C,et al. Randomi- zed phase HI study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma :an inter- group study of the European Organization for Research and Treatment of Cancer Lung Cancer Group and the Na- tional Cancer Institute of Canada[J]. J Clin Oncol,2005,23 (28) : 6881-6889.
4Sehipper PH,Niehols FC,Thomse KM,et al. Malignant pleural mesothelioma:surgical management in 285 patients [J]. Ann Thorac Surg, 2008,85(1) :257-264.
5Mirabelli D,Roberti S,Gangemi M,et al. Survival of pleural malignant mesothelioma in Italy: a population-based study [J]. Int J Cancer,2009,124(1): 194-200.
